An excelent systematic review of trials currently investigating treatment for Post-Acute COVID Syndrome (PACS)/longCOVID has been published by the Clinical Microbiology and Infection (CMI).
The review identified 388 registered trials exploring 144 unique interventions for PACS. Most target general alleviation of symptoms. As highlighted by this review, there is an urgent need for further high-quality and methodologically robust PACS treatment trials.
A Systematic Review of Trials Currently Investigating Therapeutic Modalities for Post-Acute COVID-19 Syndrome and Registered on World Health Organization International Clinical Trials Platform – Clinical Microbiology and Infection